Unknown

Dataset Information

0

Ribosomal protein gene deletions in Diamond-Blackfan anemia.


ABSTRACT: Diamond-Blackfan anemia (DBA) is a congenital BM failure syndrome characterized by hypoproliferative anemia, associated physical abnormalities, and a predisposition to cancer. Perturbations of the ribosome appear to be critically important in DBA; alterations in 9 different ribosomal protein genes have been identified in multiple unrelated families, along with rarer abnormalities of additional ribosomal proteins. However, at present, only 50% to 60% of patients have an identifiable genetic lesion by ribosomal protein gene sequencing. Using genome-wide single-nucleotide polymorphism array to evaluate for regions of recurrent copy variation, we identified deletions at known DBA-related ribosomal protein gene loci in 17% (9 of 51) of patients without an identifiable mutation, including RPS19, RPS17, RPS26, and RPL35A. No recurrent regions of copy variation at novel loci were identified. Because RPS17 is a duplicated gene with 4 copies in a diploid genome, we demonstrate haploinsufficient RPS17 expression and a small subunit ribosomal RNA processing abnormality in patients harboring RPS17 deletions. Finally, we report the novel identification of variable mosaic loss involving known DBA gene regions in 3 patients from 2 kindreds. These data suggest that ribosomal protein gene deletion is more common than previously suspected and should be considered a component of the initial genetic evaluation in cases of suspected DBA.

SUBMITTER: Farrar JE 

PROVIDER: S-EPMC3245214 | biostudies-literature | 2011 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications


Diamond-Blackfan anemia (DBA) is a congenital BM failure syndrome characterized by hypoproliferative anemia, associated physical abnormalities, and a predisposition to cancer. Perturbations of the ribosome appear to be critically important in DBA; alterations in 9 different ribosomal protein genes have been identified in multiple unrelated families, along with rarer abnormalities of additional ribosomal proteins. However, at present, only 50% to 60% of patients have an identifiable genetic lesio  ...[more]

Similar Datasets

2012-01-15 | GSE31575 | GEO
2012-01-15 | E-GEOD-31575 | biostudies-arrayexpress
| S-EPMC1698708 | biostudies-literature
| S-EPMC3972785 | biostudies-literature
| S-EPMC3590087 | biostudies-literature
| S-EPMC2518874 | biostudies-literature
| S-EPMC3372914 | biostudies-literature
| S-EPMC4925495 | biostudies-literature
| S-EPMC2820177 | biostudies-literature
| S-EPMC4058751 | biostudies-literature